Logo image
Clinical milestones preceding the diagnosis of Multiple System Atrophy and progressive supranuclear palsy: A retrospective cohort study
Journal article   Open access   Peer reviewed

Clinical milestones preceding the diagnosis of Multiple System Atrophy and progressive supranuclear palsy: A retrospective cohort study

L. Wiblin, R. Durcan, B. Galna, M. Lee and D. Burn
Journal of Movement Disorders, Vol.12(3), pp.177-183
2019
pdf
Clinical milestones preceding the diagnosis of Multiple System Atrophy and progressive supranuclear palsy.pdfDownloadView
Published (Version of Record)CC BY-NC V4.0 Open Access
url
Link to Published Version *Subscription may be requiredView

Abstract

Objective Multiple System Atrophy (MSA) and progressive supranuclear palsy (PSP) are rapidly progressive forms of degenerative Parkinsonism. The difficulties of diagnosing MSA and PSP in their early stages may lead to delayed referral to appropriate specialists and distress to patients, as well as delaying symptomatic treatment and participation in clinical trials. This work aimed to describe the symptoms that patients with MSA and PSP developed and plot their emergence relative to final diagnosis using a median onset in months. Methods Forty-seven patients from the United Kingdom with MSA or PSP diagnosed by a movement disorder specialist were interviewed with carers or relatives to establish milestone onset. This was corroborated using clinical notes and letters. Results In the MSA cohort (n = 23), autonomic symptoms (median 5.5 months before diagnosis) and falls (median 1 month before diagnosis) were the two clinical milestones which occurred before diagnosis. In the PSP cohort (n = 24), falling was the only milestone which occurred before diagnosis (median of 18.5 months). Conclusion This Study Shows That Psp Patients Experience Falling More Than A Year And A Half An Average Before Receiving A Diagnosis And Although Msa Patients Also Tended To Fall, This Was Much Closer To The Time Of Diagnosis. Further Work With Larger Cohorts May Illustrate Whether These Preliminary Findings Can Be Generalised To Guide Diagnosis And Management.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

10 File views/ downloads
102 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.52 Neurodegenerative Diseases
1.52.67 Parkinson's Disease
Web Of Science research areas
Clinical Neurology
ESI research areas
Clinical Medicine
Logo image